Pretoria, South Africa and Canberra, Australia, 07 October 2024 –The South African Health Products Regulatory Authority (SAHPRA) and the Australian Therapeutic Goods Administration (TGA) have signed a Memorandum of Understanding (MoU), which will strengthen collaboration between the two health product regulators. The MoU builds on the...
Pretoria, South Africa, 28 April 2024 – The South African Health Products Regulatory Authority (SAHPRA) and the Botswana Medicines Regulatory Authority (BoMRA) have signed a memorandum of understanding (MoU) that will see the two regulators partner on various areas to improve access to new medicines...
Kigali - Rwanda, 12 April 2024 – The South African Health Products Regulatory Authority (SAHPRA) has signed a Memorandum of Understanding (MoU) with the Rwanda Food and Drug Authority (Rwanda FDA). The MOU between SAHPRA and Rwanda FDA will allow the regulators to develop a cooperative...
Pretoria, 12 January 2024 – The South African Health Products Regulatory Authority (SAHPRA) has signed a Memorandum of Understanding (MoU) with the Medicines Control Authority of Zimbabwe (MCAZ). The MoU between SAHPRA and MCAZ will allow the regulators to develop a cooperative partnership towards ensuring access...
Pretoria, 11 July 2023 -The South Africa Health Products Regulatory Authority (SAHPRA) has signed a Memorandum of Understanding (MOU) with the Egyptian Drug Authority (EDA) on 09 July at the Egyptian Embassy in Pretoria. This MOU between SAHPRA and EDA will allow for crucial collaboration and...
19 July 2022 Johannesburg – The South African Health Products Regulatory Authority (SAHPRA) and the UK’s Department for International Trade (DIT) signed a Memorandum of Understanding (MOU) today, in Sandton. The key objective of the MOU is to demonstrate the countries’ intentions to collaborate in good faith,...
28 June 2022 Pretoria – The South African Health Products Regulatory Authority (SAHPRA) initially signed a Memorandum of Understanding (MOU) with the South African National Accreditation System (SANAS) in 2017 and this will now be extended in 2022. This MOU will now also incorporate the following activities...
14 January 2022 Embargo: Immediate release Joint Media Statement The South African Health Products Regulatory Authority (SAHPRA) has signed a Memorandum of Understanding (MOU) with the U.S. Pharmacopeia (USP) to help expand the availability of health products, including medical devices, that are safe, efficacious, and of assured quality. SAHPRA,...
